Keywords: cubist, acquires, cab-175, novartis, generics, usa-based, pharmaceuticals

Cubist acquires CAB-175 from Novartis Generics

Article | 12 August 2002

Print This

USA-based Cubist Pharmaceuticals has acquired the worldwide rights toCAB-175 from Biochemie GmbH, a unit of Novartis Generics. This is a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in